Advertisement

Barry Joel Maron, MD: A Conversation With the Editor

        Barry Maron (Figure 1) was born in Los Angeles, California, on 22 August 1941, and he grew up there. After public high school, he went to Occidental College in Los Angeles, graduating in 1963, and then he went to New Orleans, Louisiana, to Tulane University School of Medicine, where he graduated in 1968. His internship was in pediatrics at University Hospitals, University of Wisconsin, in Madison, and his 1-year residency in pediatrics was at Stanford University Medical Center in Palo Alto, California. His 2-year fellowship in pediatric cardiology was at The Johns Hopkins Hospital, where he finished in 1972. He then went to the National Heart Institute (later called National Heart, Lung, and Blood Institute) as a staff associate and senior investigator in the cardiology branch in Bethesda, Maryland, and he remained at the National Institutes of Health for 21 years, leaving in 1993 to become director of the cardiovascular research division and hypertrophic cardiomyopathy center of the Minneapolis Heart Institute Foundation in Minneapolis, Minnesota. During these last 30+ years, Barry Maron has been a world class investigator in clinical cardiology. His focus has been primarily on clinical aspects of hypertrophic cardiomyopathy, but he has done much work also in the area of sudden death in athletes and young people. His investigations have led to the publication of over 650 articles, mainly in peer review medical journals, including 23 publications in the New England Journal of Medicine (10 in the Journal of the American Medical Association and 100 in Circulation.) Dr. Maron has been a friend and colleague for >30 years. He and his wonderful wife are the parents of 2 sons, both of whom are physicians and on the path also to be major cardiovascular investigators. It was a pleasure to spend the time talking to Dr. Maron.
        Figure thumbnail gr1
        Figure 1Photograph of Dr. Maron during the interview.
        To read this article in full you will need to make a payment

        Purchase one-time access:

        Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
        One-time access price info
        • For academic or personal research use, select 'Academic and Personal'
        • For corporate R&D use, select 'Corporate R&D Professionals'

        Subscribe:

        Subscribe to American Journal of Cardiology
        Already a print subscriber? Claim online access
        Already an online subscriber? Sign in
        Institutional Access: Sign in to ScienceDirect

        Best Publications by Barry J. Maron, MD, as Selected by Him

          • Maron B.J.
          • Humphries J.O.
          • Rowe R.D.
          • Mellits D.
          Prognosis of surgically corrected coarctation of the aorta: a 20 year postoperative appraisal.
          Circulation. 1973; 47: 119-126
          • Maron B.J.
          • Ferrans V.J.
          • Henry W.L.
          • Clark C.E.
          • Redwood D.R.
          • Roberts W.C.
          • Morrow A.G.
          • Epstein S.E.
          Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH): light and electron microscopic findings.
          Circulation. 1974; 50: 436-446
          • Maron B.J.
          • Edwards J.E.
          • Henry W.L.
          • Clark C.E.
          • Bingle G.J.
          • Epstein S.E.
          Asymmetric septal hypertrophy (ASH) in infancy.
          Circulation. 1974; 50: 809-820
          • Maron B.J.
          • Henry W.L.
          • Griffith J.M.
          • Freedom R.M.
          • Kelly D.T.
          • Epstein S.E.
          Identification of congenital heart malformations in infants by real-time, two-dimensional echocardiography.
          Circulation. 1975; 52: 671-677
          • Maron B.J.
          • Henry W.L.
          • Clark C.E.
          • Redwood D.R.
          • Roberts W.C.
          • Epstein S.E.
          Asymmetric septal hypertrophy in childhood.
          Circulation. 1976; 53: 9-19
          • Maron B.J.
          • Clark C.E.
          • Goldstein R.E.
          • Epstein S.E.
          Potential role of QT interval prolongation in sudden infant death syndrome.
          Circulation. 1976; 54: 423-429
          • Maron B.J.
          • Verter J.
          • Kapur S.
          Disproportionate ventricular septal thickening in the developing normal human heart.
          Circulation. 1978; 57: 520-526
          • Maron B.J.
          • Lipson L.C.
          • Roberts W.C.
          • Savage D.D.
          • Epstein S.E.
          “Malignant” hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature deaths.
          Am J Cardiol. 1978; 41: 1133-1140
          • Maron B.J.
          • Merrill W.H.
          • Freier P.A.
          • Kent K.M.
          • Epstein S.E.
          • Morrow A.G.
          Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis.
          Circulation. 1978; 57: 1205-1213
          • Maron B.J.
          • Roberts W.C.
          Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy.
          Circulation. 1979; 59: 689-706
          • Maron B.J.
          • Epstein S.E.
          Hypertrophic cardiomyopathy: A discussion of nomenclature.
          Am J Cardiol. 1979; 43: 1242-1244
          • Maron B.J.
          • Epstein S.E.
          • Roberts W.C.
          Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries.
          Am J Cardiol. 1979; 43: 1086-1102
          • Maron B.J.
          • Roberts W.C.
          • McAllister H.A.
          • Rosing D.R.
          • Epstein S.E.
          Sudden death in young athletes.
          Circulation. 1980; 62: 218-229
          • Maron B.J.
          • Gottdiener J.S.
          • Epstein S.E.
          Patterns and significance of the distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide-angle, two-dimensional echocardiographic study of 125 patients.
          Am J Cardiol. 1981; 48: 418-428
          • Maron B.J.
          • Gottdiener J.S.
          • Bonow R.O.
          • Epstein S.E.
          Hypertrophic cardiomyopathy with unusual locations of left ventricular hypertrophy undetectable by M-mode echocardiography: identification by wide-angle, two-dimensional echocardiography.
          Circulation. 1981; 63: 409-418
          • Maron B.J.
          • Savage D.D.
          • Wolfson J.K.
          • Epstein S.E.
          Prognostic significance of 24-hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.
          Am J Cardiol. 1981; 48: 252-257
          • Maron B.J.
          • Tajik A.J.
          • Ruttenberg H.D.
          • Graham T.P.
          • Atwood G.F.
          • Victorica B.E.
          • Lie J.T.
          • Roberts W.C.
          Hypertrophic cardiomyopathy in infants: clinical features and natural history.
          Circulation. 1982; 65: 7-17
          • Maron B.J.
          • Roberts W.C.
          • Epstein S.E.
          Sudden death in hypertrophic cardiomyopathy: profile of 78 patients.
          Circulation. 1982; 65: 1388-1394
          • Spirito P.
          • Maron B.J.
          Significance of left ventricular outflow tract cross-sectional area in hypertrophic cardiomyopathy: a two-dimensional echocardiographic assessment.
          Circulation. 1983; 67: 1100-1108
          • Maron B.J.
          • Harding A.M.
          • Spirito P.
          • Roberts W.C.
          • Waller B.F.
          Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in hypertrophic cardiomyopathy.
          Circulation. 1983; 68: 282-293
          • Maron B.J.
          • Nichols P.F.
          • Pickle L.W.
          • Wesley Y.E.
          • Mulvihill J.J.
          Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography.
          Am J Cardiol. 1984; 53: 1087-1094
          • Maron B.J.
          • Gottdiener J.S.
          • Arce J.
          • Rosing D.R.
          • Wesley Y.E.
          • Epstein S.E.
          Dynamic subaortic obstruction in hypertrophic cardiomyopathy: analysis by pulsed Doppler echocardiography.
          J Am Coll Cardiol. 1985; 6: 1-15
          • Maron B.J.
          • Epstein S.E.
          • Roberts W.C.
          Causes of sudden death in competitive athletes.
          J Am Coll Cardiol. 1986; 7: 204-214
          • Maron B.J.
          Structural features of the athlete heart as defined by echocardiography.
          J Am Coll Cardiol. 1986; 7: 190-203
          • Louie E.K.
          • Maron B.J.
          Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: clinical significance, functional and morphologic features.
          J Am Coll Cardiol. 1986; 8: 57-65
          • Maron B.J.
          • Wolfson J.K.
          • Epstein S.E.
          • Roberts W.C.
          Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy.
          J Am Coll Cardiol. 1986; 8: 545-557
          • Maron B.J.
          • Spirito P.
          • Wesley Y.E.
          • Arce J.
          Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy.
          N Engl J Med. 1986; 315: 610-614
          • Maron B.J.
          • Bonow R.O.
          • Cannon R.O.
          • Leon M.B.
          • Epstein S.E.
          Hypertrophic cardiomyopathy: interrelation of clinical manifestations, pathophysiology, and therapy.
          N Engl J Med. 1987; 316 (and 844–852): 780-789
          • Louie E.K.
          • Maron B.J.
          Apical hypertrophic cardiomyopathy: clinical and two-dimensional echocardiographic assessment.
          Ann Intern Med. 1987; 106: 663-670
          • Maron B.J.
          • Bodison S.
          • Wesley Y.
          • Tucker E.
          • Green K.J.
          Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease.
          J Am Coll Cardiol. 1987; 10: 1214-1222
          • McIntosh C.L.
          • Maron B.J.
          Current operative treatment of obstructive hypertrophic cardiomyopathy.
          Circulation. 1988; 78: 487-495
          • Pelliccia A.
          • Maron B.J.
          • Spataro A.
          • Proschan M.A.
          • Spirito P.
          The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes.
          N Engl J Med. 1991; 324: 295-301
          • Klues H.G.
          • Roberts W.C.
          • Maron B.J.
          Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy: significance in producing left ventricular outflow obstruction.
          Circulation. 1991; 84: 1188-1197
          • Klues H.G.
          • Maron B.J.
          • Dollar A.L.
          • Roberts W.C.
          Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy.
          Circulation. 1992; 85: 1651-1660
          • Hecht G.M.
          • Klues H.G.
          • Roberts W.C.
          • Maron B.J.
          Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy.
          J Am Coll Cardiol. 1993; 22: 489-497
          • Maron B.J.
          • Peterson E.E.
          • Maron M.S.
          • Peterson J.E.
          Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study.
          Am J Cardiol. 1994; 73: 577-580
          • Maron B.J.
          • Kogan J.
          • Proschan M.A.
          • Hecht G.M.
          • Roberts W.C.
          Circadian variability in the occurrence of sudden cardiac death in patients with hypertrophic cardiomyopathy.
          J Am Coll Cardiol. 1994; 23: 1405-1409
          • Maron B.J.
          • Spirito P.
          Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history.
          Am J Cardiol. 1993; 72: 970-972
          • Maron B.J.
          • Pelliccia A.
          • Spirito P.
          Cardiac disease in young trained athletes: insights into methods for distinguishing athlete’s heart from structural heart disease with particular emphasis on hypertrophic cardiomyopathy.
          Circulation. 1995; 91: 1596-1601
          • Maron B.J.
          • Gardin J.M.
          • Flack J.M.
          • Gidding S.S.
          • Bild D.
          Assessment of the prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study.
          Circulation. 1995; 92: 785-789
          • Maron B.J.
          Sudden death in young athletes: lessons from the Hank Gathers affair.
          N Engl J Med. 1993; 329: 55-57
          • Maron B.J.
          • Mitchell J.H.
          26th Bethesda Conference.
          J Am Coll Cardiol. 1994; 24: 845-899
          • Fox P.R.
          • Liu S.-K.
          • Maron B.J.
          Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy::An animal model of human disease.
          Circulation. 1995; 92: 2645-2651
          • Klues H.G.
          • Schiffers A.
          • Maron B.J.
          Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy::Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients.
          J Am Coll Cardiol. 1995; 26: 1699-1708
          • Maron B.J.
          • Poliac L.
          • Kaplan J.A.
          • Mueller F.O.
          Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities.
          N Engl J Med. 1995; 333: 337-342
          • Pelliccia A.
          • Maron B.J.
          • Culasso F.
          • Spataro A.
          • Caselli G.
          Athlete’s heart in women::Echocardiographic characterization of highly trained elite female athletes.
          JAMA. 1996; 276: 211-215
          • Maron B.J.
          • Shirani J.
          • Poliac L.C.
          • Mathenge R.
          • Roberts W.C.
          • Mueller F.O.
          Sudden death in young competitive athletes: clinical, demographic and pathological profiles.
          JAMA. 1996; 276: 199-204
          • Maron B.J.
          • Thompson P.D.
          • Puffer J.C.
          • McGrew C.A.
          • Strong W.B.
          • Douglas P.S.
          • Clark L.T.
          • Mitten M.J.
          • Crawford M.H.
          • Atkins D.L.
          • Driscoll D.J.
          • Epstein A.E.
          Cardiovascular preparticipation screening of competitive athletes: a statement for Health Professionals from the Sudden Death Committee (Clinical Cardiology) and Congenital Cardiac Defects Committee (Cardiovascular Diseases in the Young) American Heart Association.
          Circulation. 1996; 94: 850-856
          • Spirito P.
          • Seidman C.E.
          • McKenna W.J.
          • Maron B.J.
          The management of hypertrophic cardiomyopathy.
          N Engl J Med. 1997; 336: 775-785
          • Maron B.J.
          Hypertrophic cardiomyopathy.
          Lancet. 1997; 350: 127-133
          • Maron B.J.
          • Spirito P.
          Implications of left ventricular remodeling in hypertrophic cardiomyopathy.
          Am J Cardiol. 1998; 81: 1339-1344
          • Glover D.W.
          • Maron B.J.
          Profile of preparticipation cardiovascular screening for high school athletes.
          JAMA. 1998; 279: 1817-1819
          • Maron B.J.
          Cardiovascular risks to young persons on the athletic field.
          Ann Intern Med. 1998; 129: 379-386
          • Maron B.J.
          • Moller J.H.
          • Seidman C.E.
          • Vincent G.M.
          • Dietz H.C.
          • Moss A.J.
          • Towbin J.A.
          • Sondheimer H.M.
          • Pyeritz R.E.
          • McGee G.
          • Epstein A.E.
          Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome.
          Circulation. 1998; 98: 1460-1471
          • Maron B.J.
          • Mitten M.J.
          • Quandt E.K.
          • Zipes D.P.
          Competitive athletes with cardiovascular disease—the case of Nicholas Knapp.
          N Engl J Med. 1998; 339;: 1632-1635
          • Maron B.J.
          • Gohman T.E.
          • Aeppli D.
          Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes.
          J Am Coll Cardiol. 1998; 32: 1881-1884
          • Maron B.J.
          • Nishimura R.A.
          • Danielson G.K.
          Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle.
          Circulation. 1998; 98: 2505-2508
          • Maron B.J.
          • Casey S.A.
          • Poliac L.C.
          • Gohman T.E.
          • Almquist A.K.
          • Aeppli D.M.
          Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
          JAMA. 1999; 281;: 650-655
          • Spirito P.
          • Maron B.J.
          Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy.
          J Am Coll Cardiol. 1999; 33: 1071-1075
          • Maron B.J.
          • Mathenge R.
          • Casey S.A.
          • Poliac L.C.
          • Longe T.F.
          Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities.
          J Am Coll Cardiol. 1999; 33: 1590-1595
          • Maron B.J.
          • Nishimura R.A.
          • McKenna W.J.
          • Rakowski H.
          • Josephson M.E.
          • Kieval R.S.
          Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind cross-over study (M-PATHY).
          Circulation. 1999; 99: 2927-2933
          • Shirani J.
          • Pick R.
          • Roberts W.C.
          • Maron B.J.
          Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death.
          J Am Coll Cardiol. 2000; 35: 36-44
          • Maron B.J.
          • Shen W.-K.
          • Link M.S.
          • Epstein A.E.
          • Almquist A.K.
          • Daubert J.P.
          • Bardy G.H.
          • Favale S.
          • Rea R.F.
          • Boriani G.
          • Estes III, N.A.M.
          • Casey S.A.
          • Stanton M.S.
          • Betocchi S.
          • Spirito P.
          Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
          N Engl J Med. 2000; 342: 365-373
          • Pfister G.C.
          • Puffer J.C.
          • Maron B.J.
          Preparticipation cardiovascular screening for US collegiate student-athletes.
          JAMA. 2000; 283: 1597-1599
          • Pelliccia A.
          • Maron B.J.
          • Culasso F.
          • Di Paolo F.M.
          • Spataro A.
          • Biffi A.
          • Caselli G.
          • Piovano P.
          Clinical significance of abnormal electrocardiographic patterns in trained athletes.
          Circulation. 2000; 102: 278-284
          • Spirito P.
          • Bellone P.
          • Harris K.M.
          • Bernabo P.
          • Bruzzi P.
          • Maron B.J.
          Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy.
          N Engl J Med. 2000; 342: 1778-1785
          • Maron B.J.
          • Olivotto I.
          • Spirito P.
          • Casey S.A.
          • Bellone P.
          • Gohman T.G.
          • Graham K.J.
          • Burton D.A.
          • Cecchi F.
          Epidemiology of hypertrophic cardiomyopathy-related death.
          Circulation. 2000; 102: 858-864
          • Maron B.J.
          Paradoxes of exercise.
          N Engl J Med. 2000; 343: 409-411
          • Maron B.J.
          • Araújo C.G.
          • Thompson P.D.
          • Fletcher G.F.
          • Bayés de Luna A.
          • Fleg J.L.
          • Pelliccia A.
          • Balady G.J.
          • Furlanello F.
          • Van Camp S.P.
          • Elosua R.
          • Chaitman B.R.
          • Bazarre T.
          Recommendations for preparticipation screening and the assessment of cardiovascular disease in Masters athletes.
          Circulation. 2001; 103: 327-334
          • Maron B.A.
          • Maron B.J.
          Sudden death and other risks associated with dry-sand beach holes.
          JAMA. 2001; 285: 1964
          • Olivotto I.
          • Cecchi F.
          • Casey S.A.
          • Dolara A.
          • Traverse J.H.
          • Maron B.J.
          Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy.
          Circulation. 2001; 104: 2517-2524
          • Biffi A.
          • Pelliccia A.
          • Verdile L.
          • Fernando F.
          • Spataro A.
          • Caselli G.
          • Santini M.
          • Maron B.J.
          Long- term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes.
          J Am Coll Cardiol. 2002; 40: 446-452
          • Pelliccia A.
          • Maron B.J.
          • de Luca R.
          • di Paolo F.M.
          • Spataro A.
          • Culasso F.
          Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning.
          Circulation. 2002; 105: 944-949
          • Maron B.J.
          • Gohman T.E.
          • Kyle S.B.
          • Estes N.A.M.
          • Link M.S.
          Clinical profile and spectrum of commotio cordis.
          JAMA. 2002; 287: 1142-1146
          • Maron B.J.
          Hypertrophic cardiomyopathy: a systematic review.
          JAMA. 2002; 287: 1308-1320
          • Maron B.J.
          • Carney K.P.
          • Lever H.M.
          • Lewis J.F.
          • Barac I.
          • Casey S.A.
          • Sherrid M.V.
          Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy.
          J Am Coll Cardiol. 2003; 41: 974-980
          • Maron B.J.
          • Casey S.A.
          • Hauser R.G.
          • Aeppli D.M.
          Clinical course of hypertrophic cardiomyopathy with survival to advanced ages.
          J Am Coll Cardiol. 2003; 42: 882-888
          • Maron B.J.
          • Poliac L.C.
          • Ashare A.B.
          • Hall W.A.
          Sudden death due to blunt neck blows in amateur hockey players.
          JAMA. 2003; 290: 599-601
          • Maron M.S.
          • Olivotto I.
          • Betocchi S.
          • Casey S.A.
          • Lesser J.R.
          • Losi M.A.
          • Cecchi F.
          • Maron B.J.
          Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
          N Engl J Med. 2003; 348: 295-303
          • Maron B.J.
          • McKenna W.J.
          • Danielson G.K.
          • Kappenberger L.J.
          • Kuhn H.J.
          • Seidman C.E.
          • Shah P.M.
          • Spencer W.H.
          • Spirito P.
          • ten Cate F.J.
          • Wigle E.D.
          American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy.
          J Am Coll Cardiol. 2003; 42: 1687-1713
          • Maron B.J.
          Sudden death in young athletes.
          N Engl J Med. 2003; 349: 1064-1075
          • Maron B.J.
          • Estes III, N.A.M.
          • Maron M.S.
          • Almquist A.K.
          • Link M.S.
          • Udelson J.
          Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
          Circulation. 2003; 107: 2872-2875
          • Maron B.J.
          • Tholakanahalli V.N.
          • Casey S.A.
          • Zenovich A.G.
          • Duprez D.
          • Aeppli D.M.
          • Cohn J.N.
          Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy.
          Circulation. 2004; 109: 984-989
          • Maron M.S.
          • Zenovich A.G.
          • Casey S.A.
          • Link M.S.
          • Udelson J.E.
          • Aeppli D.M.
          • Maron B.J.
          Significance and relationship between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
          Am J Cardiol. 2005; 95: 1329-1333
          • Maron B.J.
          • Seidman J.G.
          • Seidman C.E.
          Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy.
          J Am Coll Cardiol. 2004; l44: 2125-2132
          • Maron B.J.
          • Barry J.A.
          • Poole R.S.
          Pilots, hypertrophic cardiomyopathy and issues of aviation and public safety.
          Am J Cardiol. 2004; 93: 441-444
          • Maron B.J.
          • Dearani J.A.
          • Ommen S.R.
          • Maron M.S.
          • Schaff H.V.
          • Gersh B.J.
          • Nishimura R.A.
          The case for surgery in obstructive hypertrophic cardiomyopathy.
          J Am Coll Cardiol. 2004; 44: 2044-2053
          • Arad M.
          • Maron B.J.
          • Gorham J.M.
          • Johnson W.H.
          • Saul J.P.
          • Perez-Atayde A.R.
          • Spirito P.
          • Wright G.B.
          • Kanter R.J.
          • Seidman C.E.
          • Seidman J.G.
          Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
          N Engl J Med. 2005; 352: 362-372
          • Ommen S.R.
          • Maron B.J.
          • Olivotto I.
          • Maron M.S.
          • Cecchi F.
          • Betocchi S.
          • Gersh B.J.
          • Ackerman M.J.
          • McCully R.B.
          • Dearani J.A.
          • Schaff H.V.
          • Danielson G.K.
          • Tajik A.J.
          • Nishimura R.A.
          Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
          J Am Coll Cardiol. 2005; 46: 470-476
          • Sharkey S.W.
          • Lesser J.R.
          • Zenovich A.G.
          • Maron M.S.
          • Lindberg J.
          • Longe T.F.
          • Maron B.J.
          Acute and reversible cardiomyopathy provoked by stress in women from the United States.
          Circulation. 2005; 111: 472-479
          • Olivotto I.
          • Maron M.S.
          • Adabag A.S.
          • Casey S.A.
          • Vargiu D.
          • Link M.S.
          • Udelson J.E.
          • Cecchi F.
          • Maron B.J.
          Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.
          J Am Coll Cardiol. 2005; 46: 480-487
          • Maron B.J.
          Surgery for hypertrophic obstructive cardiomyopathy: alive and quite well.
          Circulation. 2005; 111: 2016-2018
          • Rickers C.
          • Wilke N.M.
          • Jerosch-Herold M.
          • Casey S.A.
          • Panse P.
          • Panse N.
          • Weil J.
          • Zenovich A.G.
          • Maron B.J.
          Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.
          Circulation. 2005; 112: 855-861
          • Maron B.J.
          • Zipes D.P.
          36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities.
          J Am Coll Cardiol. 2005; 45: 1312-1375
          • Paterick T.E.
          • Paterick T.J.
          • Fletcher G.F.
          • Maron B.J.
          Medical and legal issues impacting the cardiovascular evaluation of competitive athletes.
          JAMA. 2005; 294: 3011-3018
          • Harris K.M.
          • Spirito P.
          • Maron M.S.
          • Zenovich A.G.
          • Formisano F.
          • Lesser J.R.
          • Mackey-Bojack S.
          • Manning W.J.
          • Udelson J.E.
          • Maron B.J.
          Prevalence, clinical profile and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy.
          Circulation. 2006; 114: 216-225
          • Hauser R.G.
          • Maron B.J.
          Lessons from the failure and recall of an implantable cardioverter defibrillator.
          Circulation. 2005; 112: 2040-2042
          • Maron B.J.
          • Towbin J.A.
          • Thiene G.
          • Antzelevitch C.
          • Corrado D.
          • Arnett D.
          • Moss A.J.
          • Seidman C.E.
          • Young J.B.
          Contemporary definitions and classification of the cardiomyopathies.
          Circulation. 2006; 113: 1807-1816
          • Maron B.J.
          • Salberg L.
          Hypertrophic Cardiomyopathy: A Short Book Designed for Patients, Their Families and Interested Physicians. 2nd Ed. Blackwell-Futura, Malden, MA2006
          • Maron B.J.
          • Pelliccia A.
          The heart of trained athletes: cardiac remodeling and the risks of sports including sudden death.
          Circulation. 2006; 114: 1633-1644
          • Maron M.S.
          • Olivotto I.
          • Zenovich A.G.
          • Udelson J.E.
          • Link M.S.
          • Pandian N.G.
          • Kuvin J.T.
          • Nistri S.
          • Cecchi F.
          • Maron B.J.
          Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
          Circulation. 2006; 114: 2232-2239